Hospitals as a 'risk environment': An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs

Social Science and Medicine

Volumn 105, Issue , 2014, Pages 59-66

  McNeil, Ryan ^a,b   Small, Will ^a,b   Wood, Evan ^a,c   Kerr, Thomas ^a,c  

^a ST PAUL S HOSPITAL   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Canada; Discharge against medical advice; Hospital care; Injection drug users; Pain management; Qualitative research; Stigmatization

Indexed keywords

METHADONE;

DRUG USER; EPIDEMIOLOGY; HOSPITAL SECTOR; MEDICINE;

ABSTINENCE; ADULT; ANALGESIA; ARTICLE; CANADA; CLINICAL ARTICLE; CLINICAL COMPETENCE; CLINICAL PRACTICE; DISCHARGE AGAINST MEDICAL ADVICE; DRUG USE; ENVIRONMENTAL FACTOR; ETHNOLOGY; FEMALE; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL POLICY; HOSPITAL READMISSION; HUMAN; INJECTION; LENGTH OF STAY; MALE; PAIN; RISK FACTOR; SOCIAL STRUCTURE;

CANADA;

HEPATITIS C VIRUS;

CANADA; DISCHARGE AGAINST MEDICAL ADVICE; HOSPITAL CARE; INJECTION DRUG USERS; PAIN MANAGEMENT; QUALITATIVE RESEARCH; STIGMATIZATION;

ADULT; CANADA; COHORT STUDIES; DRUG USERS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PAIN MANAGEMENT; PATIENT DISCHARGE; PATIENT DROPOUTS; QUALITATIVE RESEARCH; RISK; SOCIAL ENVIRONMENT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84896822772     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2014.01.010     Document Type: Article

References (50)

1. Aceijas C., Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy 2007, 18(5):352-358.
2. Anis A.H., Sun H., Guh D.P., Palepu A., Schechter M.T., O'Shaughnessy M.V. Leaving hospital against medical advice among HIV-positive patients. Canadian Medical Association Journal 2002, 167(6):633-637.
3. Beletsky L., Davis C.S., Anderson E., Burris S. The law (and politics) of safe injection facilities in the United States. American Journal of Public Health 2008, 98(2):231-237.
4. Berg K.M., Arnsten J.H., Sacajiu G., Karasz A. Providers' experiences treating chronic pain among opioid-dependent drug users. Journal of General Internal Medicine 2009, 24(4):482-488.
5. Prescription review committee prescribing principles 2012, British Columbia College of Physicians and Surgeons, Author, Vancouver, BC.
6. Chan A.C., Palepu A., Guh D.P., Sun H., Schechter M.T., O'Shaughnessy M.V., et al. HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. Journal of Acquired Immune Deficiency Syndromes 2004, 35(1):56-59.
7. Choi M., Kim H., Qian H., Palepu A. Readmission rates of patients discharged against medical advice: a matched cohort study. PLoS ONE 2011, 6(9):e24459.
8. Cooper H., Brady J.E., Ciccarone D., Tempalski B., Gostnell K., Friedman S.R. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clinical Infectious Diseases 2007, 45(9):1200-1203.
9. Corbin J.M., Strauss A.L. Basics of qualitative research: Techniques and procedures for developing grounded theory 2008, Sage Publications, Los Angeles, Calif. 3rd ed.
10. Fairbairn N., Milloy M.J., Zhang R., Lai C., Grafstein E., Kerr T., et al. Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting. The Journal of Emergency Medicine 2011, 43(2):236-243.
11. Fairbairn N., Small W., Shannon K., Wood E., Kerr T. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility. Social Science & Medicine 2008, 67(5):817-823.
12. Gebo K.A., Diener-West M., Moore R.D. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. Journal of Acquired Immune Deficiency Syndromes 2003, 34(2):165-173.
13. Glasgow J.M., Vaughn-Sarrazin M., Kaboli P.J. Leaving against medical advice (AMA): risk of 30-day mortality and hospital readmission. Journal of General Internal Medicine 2010, 25(9):926-929.
14. Hwang S.W., Li J., Gupta R., Chien V., Martin R.E. What happens to patients who leave hospital against medical advice?. Canadian Medical Association Journal 2003, 168(4):417-420.
15. Jeremiah J., Stein M.D. Who leaves against medical advice?. Journal of General Internal Medicine 1995, 10(7):403-405.
16. Kerr T., Small W., Moore D., Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. International Journal of Drug Policy 2007, 18(1):37-45.
17. Kerr T., Wood E., Grafstein E., Ishida T., Shannon K., Lai C., et al. High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health 2005, 27(1):62-66.
18. Krusi A., Small W., Wood E., Kerr T. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. AIDS Care 2009, 21(5):638-644.
19. Lloyd-Smith E., Wood E., Zhang R., Tyndall M.W., Montaner J.S., Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health 2008, 8:405.
20. Lopez A.M., Bourgois P., Wenger L.D., Lorvick J., Martinez A.N., Kral A.H. Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco. International Journal of Drug Policy 2013, 24(2):101-109.
21. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet 2008, 372(9651):1733-1745.
22. McInnes C.W., Druytz E., Harvard S.S., Gilbert M., Tyndall M.W., Lima V.D., et al. HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduction Journal 2009, 6(5).
23. Merrill J.O., Rhodes L.A., Deyo R.A., Marlatt G.A., Bradley K.A. Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet. Journal of General Internal Medicine 2002, 17(5):327-333.
24. Miller N.S., Sheppard L.M., Colenda C.C., Magen J.D. Why physicians are unprepared to treat patients who have alcohol- and Drug-related disorders. Academic Medicine 2001, 76(5):410-418.
25. Neale J., Tompkins C., Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health & Social Care in the Community 2008, 16(2):147-154.
26. Neighbor M.L., Dance T.R., Hawk M., Kohn M.A. Heightened pain perception in illicit substance-using patients in the ED: implications for management. The American Journal of Emergency Medicine 2011, 29(1):50-56.
27. Palepu A., Tyndall M.W., Leon H., Muller J., O'Shaughnessy M.V., Schechter M.T., et al. Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal 2001, 165(4):415-420.
28. Passik S.D., Kirsh K.L., Donaghy K.B., Portenoy R.K. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. The Clinical Journal of Pain 2006, 22(2):173-181.
29. Pauly B. Shifting moral values to enhance access to health care: harm reduction as a context for ethical nursing practice. International Journal of Drug Policy 2008, 19(3):195-204.
30. Providence Health Care. (N.D). Patient rights+responsibilities: Safety during your stay. Retrieved April 10, 2013, from. http://www.providencehealthcare.org/hospitals-residences/st-pauls-hospital/info-patients-families/patient-rights-responsibilities/safety.
31. Quesada J., Hart L.K., Bourgois P. Structural vulnerability and health: latino migrant laborers in the United States. Medical Anthropology 2011, 30(4):339-362.
32. Rachlis B.S., Kerr T., Montaner J.S., Wood E. Harm reduction in hospitals: is it time?. Harm Reduction Journal 2009, 6:19.
33. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. International Journal of Drug Policy 2002, 13(2):85-94.
34. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. International Journal of Drug Policy 2009, 20(3):193-201.
35. Rhodes T., Kimber J., Small W., Fitzgerald J., Kerr T., Hickman M., et al. Public injecting and the need for "safer environment interventions" in the reduction of drug-related harm. Addiction 2006, 101(10):1384-1393.
36. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 2005, 61(5):1026-1044.
37. Rhodes T., Watts L., Davies S., Martin A., Smith J., Clark D., et al. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales. Social Science & Medicine 2007, 65(3):572-585.
38. Riddell C., Riddell R. Welfare checks, drug consumption, and health. Journal of Human Resources 2006, XLI(1):138-161.
39. Scheper-Hughes N. Death without weeping: The violence of everyday life in Brazil 1992, University of California Press, Berkeley.
40. Shannon K., Kerr T., Allinott S., Chettiar J., Shoveller J., Tyndall M.W. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Social Science & Medicine 2008, 66(4):911-921.
41. Small W., Rhodes T., Wood E., Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. International Journal of Drug Policy 2007, 18(1):27-36.
42. Small W., Van Borek N., Fairbairn N., Wood E., Kerr T. Access to health and social services for IDU: the impact of a medically supervised injection facility. Drug and alcohol review 2009, 28(4):341-346.
43. Small W., Wood E., Lloyd-Smith E., Tyndall M., Kerr T. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug and Alcohol Dependence 2008, 98(1-2):159-162.
44. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G.A., Rekart M.L., Montaner J.S.G., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997, 11(8):F59-F65.
45. Vancouver Coastal Health Clinical practice document: Alcohol and illegal substances 2008, Vancouver Coastal Health, Vancouver, Canada.
46. Wagner K.D., Davidson P.J., Pollini R.A., Strathdee S.A., Washburn R., Palinkas L.A. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. International Journal of Drug Policy 2012, 23(1):54-61.
47. Warner-Smith M., Darke S., Day C. Morbidity associated with non-fatal heroin overdose. Addiction 2002, 97(8):963-967.
48. Wood E., Montaner J.S., Yip B., Tyndall M.W., Schechter M.T., O'Shaughnessy M.V., et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Canadian Medical Association Journal 2003, 169(7):656-661.
49. Wood R.A., Zettel P., Stewart W. The Dr. Peter Centre: harm reduction nursing. The Canadian Nurse 2003, 99(5):20-24.
50. Yong T.Y., Fok J.S., Hakendorf P., Ben-Tovim D., Thompson C.H., Li J.Y. Characteristics and outcomes of discharges against medical advice among hospitalized patients. Internal Medicine Journal 2013, 43(7):798-802.